UNICRI and AIFA collaborate to protect human rights and promote ethical and legal standards for clinical drug trials in developing countries
UNICRI has recently received a contribution from the Italian Medicines Agency (AIFA) to implemen
Strengthening the ethical and human rights component of the drug control initiatives is at the basis of the collaboration that UNICRI has established with the Ministry of Health, since 1991 and, more recently, with the Department for Drug Policy o
The Georgian Interagency Coordinating Council for Countering Chemical, Biological, Radiological and Nuclear (CBRN) Threats has officially approved the CBRN National Action Plan for Georgia. The Plan, approved 10 March 2015, was developed with the support of the European Union CBRN Risk Mitigation Centres of Excellence (CoE) Initiative. Georgia is the first CoE partner country to have officially adopted a national action plan to counter the risks posed by chemical, biological, radiological and nuclear materials.
Strengthening the ethical and human rights component of the drug control initiatives is at the basis of the collaboration that UNICRI has established with the Ministry of Health, since 1991 and, more recently, with the Department for Drug Policy of its Host Country, Italy, to develop tools and instruments for professional knowledge sharing. This includes the establishment of a clearinghouse on drug prevention and related social phenomena, the publishing of a specialized scientific journal, and an advanced training programme for continuing education in drug prevention and control.
African Malaria Network Trust – AMANET
Wenceslaus L. Kilama, Managing Trustee, Tanzania Commission for Science and Technology
Roma Chilengi, Clinical Trials Coordinator, Tanzania Commission for Science and Technology
Centre for the AIDS Programme of Research in South Africa – CAPRISA
Jerome A. Singh, Head of the CAPRISA Bioethics Programme, Nelson R. Mandela School of Medicine, University of KwalaZulu-Natal